青光眼及其治疗与白内障的关联:UK Biobank横断面研究
完全调整模型显示青光眼与白内障较高odds相关(OR 3.09,95%CI 2.73-3.49),局部用药者OR 3.14(95%CI 2.54-3.89),青光眼手术者OR最高达12(95%CI 8.99-16.2)。结论认为青光眼及其管理可能与白内障odds增加相关,但一线激光亚组因样本量有限无法可靠估计,需纵向研究验证。
要点
- 青光眼与白内障较高odds独立相关,完全调整后OR 3.09(95%CI 2.73-3.49)。
- 使用局部青光眼药物者白内障OR 3.14(95%CI 2.54-3.89)。
- 接受青光眼手术者白内障odds最高,OR 12(95%CI 8.99-16.2)。
核心结论
- 青光眼及其管理(局部药物、手术)与白内障odds增加相关,但一线激光亚组因样本量有限无法可靠估计。
研究设计与样本
- UK Biobank 2006至2010年招募参与者的横断面观察性研究,分析完成于2026年4月。
- 参与者分为无青光眼、青光眼无记录治疗、局部药物、激光手术或青光眼手术组,采用多因素logistic回归估计白内障OR(95%CI),调整人口学、临床合并症和眼部参数。
主要发现
- 完全调整模型中,青光眼与白内障较高odds相关(OR 3.09,95%CI 2.73-3.49,p<0.01)。
- 使用局部青光眼治疗者白内障OR 3.14(95%CI 2.54-3.89,p<0.01)。
- 接受青光眼手术者白内障odds最高(OR 12,95%CI 8.99-16.2,p<0.01)。
- 采用替代病例定义的敏感性分析结果一致。
关键数值与推荐
- 青光眼vs无青光眼:白内障OR 3.09(95%CI 2.73-3.49,p<0.01)。
- 局部青光眼药物vs无青光眼:白内障OR 3.14(95%CI 2.54-3.89,p<0.01)。
- 青光眼手术vs无青光眼:白内障OR 12(95%CI 8.99-16.2,p<0.01)。
临床怎么用
- 对青光眼患者,尤其使用局部药物或接受手术者,应关注白内障发生风险并考虑监测。
- 研究结果可能为老龄化人群中白内障监测和手术时机提供参考,但需纵向研究确认。
局限性
- 横断面设计无法推断因果关系。
- 一线激光亚组因样本量有限,调整分析无法可靠估计。
- 青光眼和白内障定义依赖自我报告和ICD编码,可能存在错分。
- 需纵向研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glaucoma and cataract are among the leading causes of visual impairment worldwide. Both are prevalent in older adults, but it remains unclear whether their association is independent of age and shared risk factors. AIM: To assess whether glaucoma and its treatments are independently associated with cataract odds using a population-based sample. METHODS: Cross-sectional analysis of UK Biobank participants recruited between 2006 and 2010. (Analysis completed in April 2026). Glaucoma and cataract were defined using self-report and International Classification of Diseases-codes from hospital and primary care records. Participants were grouped as no glaucoma, glaucoma with no recorded treatment, topical medications, laser procedures or glaucoma surgery. Multivariable logistic regression estimated cataract odds ratios (OR, 95% CI). Models adjusted for demographic variables, clinical comorbidities and ocular parameters. RESULTS: Among 497 109 adults, glaucoma was associated with higher odds of cataract (OR 3.09, 95% CI 2.73 to 3.49, p<0.01) in fully adjusted models. Odds were higher among those using topical glaucoma treatments (OR 3.14, 95% CI 2.54 to 3.89, p<0.01). Participants who had undergone glaucoma surgery had the highest odds of cataract (OR 12, 95% CI 8.99 to 16.2, p<0.01). Findings were consistent in sensitivity analyses using alternative case definitions. CONCLUSION: Glaucoma and its management were associated with increased odds of cataract, although the adjusted analysis for the first-line laser subgroup was limited by sample size and cannot be reliably estimated. Longitudinal studies are needed; if confirmed, the results may inform cataract surveillance and timing of operation, relevant in ageing populations.
引用
- Chen AY, Khoo A, Danesh-Meyer HV, et al. Association of glaucoma and glaucoma treatments with cataract in the UK Biobank: a cross-sectional observational study. Br J Ophthalmol. 2026. PMID: 42618335. doi:10.1136/bjo-2026-329580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。